One year experience with intravenous treprostinil in pulmonary arterial hypertension (PAH) patients

被引：0
|
作者：
McLaughlin, VV [1 ]
Barst, R [1 ]
Gomberg-Maitland, M [1 ]
Tapson, V [1 ]
Krichman, A [1 ]
Widlitz, A [1 ]
Rich, S [1 ]
Benza, R [1 ]
机构：
[1] Univ Michigan, Ann Arbor, MI 48109 USA
来源：
CHEST | 2005年 / 128卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：160S / 160S
页数：1
相关论文
共 50 条
  • [1] One-year experience with intravenous treprostinil for pulmonary arterial hypertension
    Benza, Raymond L.
    Tapson, Victor F.
    Gomberg-Maitland, Mardi
    Poms, Abigail
    Barst, Robyn J.
    McLaughlin, Vallerie V.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2013, 32 (09): : 889 - 896
  • [2] Inhaled Treprostinil (it) In Management Of Pulmonary Arterial Hypertension (pah) - Experience In Central Valley Of California
    Ronaghi, R.
    Ghahremani-Ghajar, M.
    Voora, R.
    Balasubramanian, V.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [3] Intravenous treprostinil as an add-on therapy in patients with pulmonary arterial hypertension
    Olsson, Karen M.
    Richter, Manuel J.
    Kamp, Jan C.
    Gall, Henning
    Heine, Alexander
    Ghofrani, Hossein-Ardeshir
    Fuge, Jan
    Ewert, Ralf
    Hoeper, Marius M.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2019, 38 (07): : 748 - 756
  • [4] Rapid switch from intravenous epoprostenol to intravenous treprostinil in patients with pulmonary arterial hypertension
    Sitbon, Olivier
    Manes, Alessandra
    Jais, Xavier
    Pallazini, Massimiliano
    Humbert, Marc
    Presotto, Luis
    de Nillette, Louis
    Zaccardelli, Divid
    Davis, Gillian
    Jeff, Roger
    Simonneau, Gerald
    Galie, Naareno
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2007, 49 (01) : 1 - 5
  • [5] Multicenter experience with the rapid transition to intravenous treprostinil from epoprostenol in pulmonary arterial hypertension
    Shapiro, Shelley
    Waxman, Aaron
    Schilz, Robert
    Strootman, Deb
    Rollins, Kristan
    Feldman, B. Jeremy
    [J]. CHEST, 2007, 132 (04) : 635S - 635S
  • [6] Risk assessment and prognosis in patients with pulmonary arterial hypertension receiving intravenous treprostinil
    Olsson, Karen
    Richter, Manuel
    Kamp, Jan C.
    Gall, Henning
    Heine, Alexander
    Ghofrani, Hossein-Ardeshir
    Fuge, Jan
    Ewert, Ralf
    Hoeper, Marius M.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [7] Commentary on Symptom Experience of Pulmonary Arterial Hypertension (PAH) Patients
    Khan, Ehsan Ullah
    [J]. CLINICAL NURSING RESEARCH, 2011, 20 (02) : 135 - 143
  • [8] Transition of stable pediatric patients with pulmonary arterial hypertension from intravenous epoprostenol to intravenous treprostinil
    Ivy, D. Dunbar
    Claussen, Lori
    Doran, Aimee
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2007, 99 (05): : 696 - 698
  • [9] Experience with subcutaneous treprostinil in children with pulmonary arterial hypertension
    Vernetta, Alba Torrent
    Amigo, Sandra Rovira
    Serrano, Ignacio Iglesias
    Morillo, Maria
    Messa, Ines de Mir
    Gartner, Silvia
    Brotons, Dimpna Albert
    Galdo, Antonio Moreno
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [10] Sustained Plasma Concentrations of Treprostinil Following Chronic Dosing in Patients with Pulmonary Arterial Hypertension (PAH)
    White, R. J.
    Allen, R.
    Torres, F.
    Jerjes, C.
    Pulido, T.
    Carroll, J.
    Yehle, D.
    Laliberte, K.
    Mottola, D.
    Galie, N.
    Simmoneau, G.
    Tapson, V. F.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
12345